logo

Trevena, Inc. (TRVN)



Trade TRVN now with
  Date
  Headline
6/2/2020 7:13:11 AM Trevena Announces Collaboration With Imperial College London To Evaluate TRV027 In COVID-19 Patients
3/12/2020 7:14:29 AM Trevena Q4 Net Loss Attributable $6.4 Mln Or $0.07 Per Share
3/5/2020 7:19:00 AM Trevena Reports FDA Set PDUFA Date Of August 7, 2020 For Oliceridine
2/10/2020 7:04:39 AM Trevena Resubmits NDA To FDA For IV Oliceridine
12/23/2019 7:09:47 AM Trevena Begins Proof-of-Concept Study For TRV734 For Potential Treatment Of Opioid Use Disorder
6/27/2019 7:14:09 AM Trevena Appoints Barry Shin As CFO
3/13/2019 7:18:54 AM Trevena Q4 Net Loss Attributable $8.0 Mln Or $0.10 Per Share
1/30/2019 7:10:47 AM Trevena Plans $10 Mln Direct Offering Of Common Stock
1/28/2019 7:07:00 AM Trevena Reports Receipt Of Type A Meeting Minutes And Provides Regulatory Update For Oliceridine
10/11/2018 7:07:53 AM Trevena Stock Trading Halted; FDA Advisory Committee To Review Oliceridine For TModerate To Severe Acute Pain